This Article is From Sep 09, 2021

No Scientific Body Suggests Kids' Vaccination For School Opening: Centre

NITI Aayog member (Health) V K Paul said whether children have to be vaccinated and who among them should get the jabs is an evolving scientific and public health discourse.

Advertisement
India News

Vaccination of school staff and parents is desirable for opening schools, Centre said. (Representational)

New Delhi:

The centre on Thursday said no scientific body suggests that vaccination of children against COVID-19 should be a condition for reopening schools, but inoculation of teachers, school employees and parents is desirable.

At a press conference, NITI Aayog member (Health) V K Paul said whether children have to be vaccinated and who among them should get the jabs is an evolving scientific and public health discourse.

Only a limited number of nations have introduced vaccination of children so far, he said.

Besides the aspect of vaccination, the overall epidemiological situation has to be safe for opening schools, he said.

Most importantly, following standard operating procedures about ventilation, seating arrangements, staggered classes and wearing masks among others will be critical when schools reopen, Paul stressed.

Advertisement

"No scientific body, epidemiology, no evidence suggests that vaccination against COVID-19 should be a condition to reopen schools. However, inoculation of teachers, other school employees and parents is desirable," he told the press conference.

"There is no WHO recommendation also that we should move in that direction for reasons such as low mortality and high incidence of asymptomatic infection. We as a nation and government are working actively in the direction of scientific validation of our vaccines for potential use in children."

Advertisement

Mr Paul said that Zydus vaccine has also already been licenced for children. How and when it will be administered is being discussed by scientific bodies, Paul said, adding that the trial of Covaxin on children is nearing completion.

Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.

Advertisement